ELIGARD

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Turkey, South Africa

Active ingredients

The drug ELIGARD contains one active pharmaceutical ingredient (API):

1 Leuprorelin UNII 37JNS02E7V - LEUPROLIDE ACETATE

Leuprorelin is inactive when given orally due to poor membrane permeability and an almost complete inactivation by intestinal proteolytic enzymes. Leuprorelin has potent LHRH agonist properties when given during short-term and intermittent therapy, however, when administered in a continuous, nonpulsatile manner, LHRH analogs induce inhibition of gonadotropin secretion and suppression of testicular steroidogenesis. Read about Leuprorelin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L02AE02	Leuprorelin	L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues
Discover more medicines within L02AE02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8707G, 8708H, 8709J, 8859G
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 534213080009803, 534214090010603, 534214090010703
Country: CA	Health Products and Food Branch	Identifier(s): 02248239, 02248240, 02248999, 02268892
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 30060-12-11
Country: EE	Ravimiamet	Identifier(s): 1156755, 1156766, 1156801, 1156812, 1287570, 1287581
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 66620, 66627, 69357
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 020427, 059569, 513528
Country: FR	Base de données publique des médicaments	Identifier(s): 60639255, 62403976, 69267482
Country: HK	Department of Health Drug Office	Identifier(s): 61498, 61499, 61500
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-020927799, HR-H-509836130
Country: IE	Health Products Regulatory Authority	Identifier(s): 88531, 88534, 88598
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7881, 7882, 7883
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004419, 1004420, 1016980, 1016981, 1024891, 1025282
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 626M2003
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 78344, 78352, 85111
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100136392, 100136400, 100189773
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67702006, W67702007, W67816003, W67816004
Country: SG	Health Sciences Authority	Identifier(s): 14511P, 14512P, 14513P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683161947067, 8699559770148, 8699559770155
Country: ZA	Health Products Regulatory Authority	Identifier(s): A39/26/0650, A39/26/0651